Pharmacovigilance (PV) Market Quadruples by 2023; with a ~ 13.14 % of Whooping CAGR: BioClinica, LabCorp, Capgemini, Clinquest Group B.V, iMEDGlobal, ITClinical, Cognizant, ArisGlobal LLC, ICON plc, IBM and Accenture

New Market Research Reports Title "Pharmacovigilance (PV) Market 2018" Has Been Added to Crystal Market Research Report database.

Pharmacovigilance (PV) Market - Competitive Insights:

The leading players in the market are BioClinica, LabCorp, Capgemini, Clinquest Group B.V, iMEDGlobal, ITClinical, Cognizant, ArisGlobal LLC, ICON plc, IBM and Accenture. This industry is witnessing a tremendous boost due to patent expiration of branded drugs and rising number of new drug developments. This has encouraged several local and international pharmacovigilance service providers in the market.

Sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC04677 .

Pharmacovigilance (PV) Market - Industry Outlook and Trend Analysis:

The Pharmacovigilance (PV) Market was worth USD 2.78 billion in 2014 and is expected to reach approximately USD 8.46 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.14% during the forecast period. Expanding rate of Adverse Drug Reactions (ADRs) is anticipated to quicken the interest for pharmacovigilance services over the conjecture time frame. Developing prevalence of chronic diseases is another significant benefactor for the PV development. Treatment of these chronic diseases require uptake of blend of medications bringing about ADR. To curtail this issue, PV administrations are used. Also, presence of charitable association for spreading the awareness associated with PV, for example, International Society of Pharmacovigilance (ISoP) is anticipated to encourage the selection of PV amid the conjecture time frame as it is concentrating on upgrading safe and appropriate use of medications at worldwide level. Increasing government activities relating to adoption of PV administrations is foreseen to impel the business development in the following years.

Pharmacovigilance (PV) Market - Service Provider Outlook and Trend Analysis:

Contract outsourcing held the prevailing share in 2016 and is anticipated to witness quickest developing fragment in the following years. It is because of the advantages related with outsourcing such as resource flexibility, risk mitigation, reduction in fixed cost, and reduction of upfront investments. Contract outsourcing associations give arrangements, for example, process plan Standard Operating Procedure (SOP), PV audits, and other customized services.

Pharmacovigilance (PV) Market - Type Outlook and Trend Analysis:

Spontaneous reporting captured the biggest share of the pharmacovigilance market in 2016, attributable to wide usage in location of new, genuine and uncommon ADRs and serves as a proficient and economical technique. Wide use of surveillance reports created through this technique by pharmaceutical organizations and regulatory authorities is likewise in charge of capitalizing the share of the overall industry of spontaneous reporting. Cohort event monitoring (CEM) is anticipated to be the quickest developing fragment inferable from its expanding application in discovery of extensive variety of unfavourable clinical events.

Pharmacovigilance (PV) Market - Clinical Trial Phase Outlook and Trend Analysis:

The Phase IV (Post marketing) clinical trial section ruled the market in 2016. PV arrangements function as an extra security measure for the drug undergoing clinical trials. Stage IV is fundamental phase of whole clinical trials as unsuspected unfavourable medication responses can be recognized in this stage. Consequently, the information gathered and surveyed amid this stage is anticipated to be of the most elevated significance. The Phase III section is foreseen to witness lucrative development.

The Pharmacovigilance (PV) Market is segmented as follows-

Pharmacovigilance (PV) Market - By Clinical Trial Phase:

Pre-clinical
Phase I
Phase II
Phase III
Phase IV

Pharmacovigilance (PV) Market - By Service Provider:

In-house
Contract Outsourcing

Pharmacovigilance (PV) Market - By Type:

Intensified ADR Reporting
Targeted Spontaneous Reporting
Spontaneous Reporting
EHR Mining
Cohort Event Monitoring

Pharmacovigilance (PV) Market - By End User:

Research Organizations
Hospitals
Industrial

Browse complete report with TOC: https://www.crystalmarketresearch.com/report/pharmacovigilance-pv-market .

Pharmacovigilance (PV) Market - End User outlook and Trend Analysis:

In 2016, hospitals represented the biggest revenue share of the pharmacovigilance market based on end use. Hospitals serves columnist associations, which report the ADRs, happened amid a specific time period, to administrative experts keeping in mind the end goal to find out the requirement for post marketing surveillance. Rising frequency of ADRs and medication errors are anticipated to drive the hospital section development over the gauge time frame.

Pharmacovigilance (PV) Market - By Region:

North America - U.S, Canada, Mexico

Europe - Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific

Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Pharmacovigilance (PV) Market - Regional Outlook and Trend Analysis:

North America captured the biggest revenue share in 2016, attributable to presence of key pharmaceutical and medicinal devices players in this area, adding to the general income in this area. Rising level of drug abuse and related unfavourable drug reactions is a main source of death and morbidity. The previously mentioned components are high development rendering factors for the pharmacovigilance market in North America. Asia Pacific is anticipated to develop at lucrative rate, owing to accessibility of expansive number of outsourcing associations.

Pharmacovigilance (PV) Market - Table of Contents:

1. Introduction
2. Executive Summary
3. Market Overview
4. Market Analysis by Regions
5. Pharmacovigilance (PV) Market, By Trial Phase
6. Pharmacovigilance (PV) Market, By Service Provider
7. Pharmacovigilance (PV) Market, By Type
8. Pharmacovigilance (PV) Market, By End User
9. Pharmacovigilance (PV) Market, By Region
10.Company Profiles
11.Global Pharmacovigilance (PV) Market Competition, by Manufacturer
12.Pharmacovigilance (PV) Market Forecast (2018-2023)

What our report offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends.

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pharmacovigilance (PV) market based on product and application. It also provides market size and forecast till 2023 for overall Pharmacovigilance (PV) market with respect to five major regions, namely; North America, Europe, Asia-Pacific, Rest of the World, which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Get more information of this report: https://www.crystalmarketresearch.com/send-an-enquiry/HC04677 .

Also, key Pharmacovigilance (PV) market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered.

Continued…

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.